Search results
Author(s):
Subodh Verma
Added:
9 months ago
ESC Congress 2025 - NEWTON-CABG finds evolocumab with regular statin therapy did not improve vein graft patency after coronary artery bypass graft (CABG) surgery in the short-term.Dr Subodh Verma and Dr Lawrence Leiter (University of Toronto, Toronto, CA) join us to discuss findings from NEWTON-CABG CardioLink-5 (NCT03900026). The investigator-initiated multicenter, randomised, placebo-controlled…
View more
Author(s):
Andrea M Steely
Added:
7 months ago
Navigate the evolving landscape of surgical coronary revascularization with Dr Andrea SteelyThis presentation, part of the Complex Cases track in Women As One's CLIMB® 2025 Skills Training Program, provides a comprehensive overview of traditional and contemporary approaches to treating coronary artery disease.Dr Steely examines traditional coronary artery bypass grafting (CABG) alongside…
View more
Author(s):
Mahmoud Izraiq
,
Nail Alshoubaki
,
Omran A Abu-Dhaim
,
et al
Added:
1 year ago
Author(s):
Evald Høj Christiansen
Added:
7 months ago
TCT 2025 - 10-year findings from NOBLE showed no safety concerns for percutaneous coronary intervention (PCI) compared to coronary artery bypass surgery (CABG) for the treatment of left main coronary artery (LMCA) disease.Dr Evald Høj Christiansen (Aarhus University Hospital, Aarhus, DK) joins us to share the 10-year mortality findings from the NOBLE trial, investigating PCI vs CABG in LMCA…
View more
Author(s):
Khaled A Shams
,
Hossameldin Hussein
,
Soha Romeih
,
et al
Added:
1 year ago
Left Main Coronary Artery Intervention
Author(s):
Duy Cao Phuong Le
,
Hoa The Bui
,
Quan Duy Vo
Added:
2 years ago
Original Research
Author(s):
Harriette Van Spall
,
Stefan James
Added:
1 year ago
ESC Congress 2024 — SWEDEGRAFT does not support the routine use of no-touch vein harvest compared to the standard technique.Dr Harriette Van Spall (McMaster University, CA) sits down with principal investigator Prof Stefan James (Uppsala University, SE) to discuss results of the SWEDEGRAFT trial (NCT03501303; Uppsala University).The SWEDEGRAFT trial is a prospective, binational, multicenter, open…
View more
Author(s):
Bruno Scheller
Added:
1 day ago
EuroPCR 2026 – Prof Bruno Scheller (Saarland University Hospital, Homburg, DE) joins us to explore the evolving role of drug-coated balloons in coronary intervention, discussing the latest trial evidence and how it is shaping clinical practice.Interview Questions:How has the role of DCBs in coronary intervention evolved over recent years?What does the latest trial evidence add to our…
View more
Author(s):
Patrick W Serruys
Added:
2 years ago
CRT 2024 — Prof Patrick W Serruys (National University of Ireland, Galway, US) joins us to discuss learning from the SYNTAX trial.The SYNTAX trial is a randomized controlled trial designed to evaluate the efficacy and safety of percutaneous coronary intervention (PCI) with polymer-based paclitaxel-eluting TAXUS stents versus coronary artery bypass grafting (CABG) in patients with complex coronary…
View more
Coronary Calcification: From Pathophysiology to Outcomes
Author(s):
Angela McInerney
,
Seán O Hynes
,
Nieves Gonzalo
Added:
1 year ago
Review Article